This February 17th – 20th, researchers from OBRI will travel to Lake Louise Alberta to present their latest research at the Canadian Rheumatology Association (CRA) Annual Scientific Meeting.
Focused on optimizing quality in rheumatology care, the meeting brings together Canadian and International rheumatologists, researchers, patients, and stakeholders to share scientific discoveries, innovative research, and evidence-informed care practices.
Presentations from OBRI will cover a broad range of topics such as: persistence with biologic monotherapy compared with DMARD combination therapy in patients with RA, contributions of social determinants of health on treatment response in RA, rates of primary and secondary failure of anti-TNF in RA patients, biologic treatment survival patterns in RA, and attrition and participant characteristics in RA, among others.
We’re excited to share our research and connect with members of the rheumatology and scientific community working to improve treatment options and quality of care for patients. For more information on the CRA Annual Scientific Meeting, visit the CRA’s website: http://rheum.ca/en.